| 0.82 Data as of 11:12am ET |  0.00 / 0.00%Today’s Change | 0.71 Today|||52-Week Range 1.72 | -28.70% Year-to-Date |
| Previous close | 0.82 |
| Today’s open | 0.78 |
| Day’s range | 0.78 - 0.82 |
| Volume | 3,619 |
| Average volume (3 months) | 18,891 |
| Market cap | $10.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -900.00% |
| Earnings growth (this year) | +93.75% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +5.68% |
| P/E ratio | NM |
| Price/Sales | 0.92 |
| Price/Book | 1.11 |
| Today’s change | Today’s % change | |
|---|---|---|
| --Islet Sciences Inc | +0.01 | +5.00% |
| BASIBioanalytical System... | +0.01 | +0.54% |
| OPXAOpexa Therapeutics I... | +0.02 | +1.16% |
| ADMDAdvanced Medical Iso... | +0.01 | +8.43% |
| Last reporting date | May 16, 2013 |
| EPS forecast (this quarter) | $0.00 |
| Annual revenue (last year) | $16.4M |
| Annual profit (last year) | -$1.1M |
| Net profit margin | -6.61% |
Sector Process Industries |
Industry Chemicals: Specialty |
President, CEO, CFO, Director & CAO Daniel Bryan O'Brien |
Director Robert N. O'Brien, PhD |
Corporate headquarters Victoria, British Columbia |
.
